Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of 89.43% is 39% above its 5-year average of 64.30%, around the middle of its 5-year range (37.52%–114.31%).
As of the fiscal period ended Tuesday, June 30, 2026. 2.17% above its 12-month average of 87.53%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): 89.43%.
RETURN ON EQUITY (ROE)
89.43%
RETURN ON EQUITY (ROE) AVG TTM
87.53%
RETURN ON EQUITY (ROE) AVG 3Y
75.48%
RETURN ON EQUITY (ROE) AVG 5Y
64.30%
RETURN ON EQUITY (ROE) AVG 10Y
63.71%
RETURN ON EQUITY (ROE) AVG 15Y
51.42%
RETURN ON EQUITY (ROE) AVG 20Y
40.58%
CURRENT VS TTM AVG
+2.17%
CURRENT VS 3Y AVG
+18.48%
CURRENT VS 5Y AVG
+39.09%
CURRENT VS 10Y AVG
+40.38%
CURRENT VS 15Y AVG
+73.94%
CURRENT VS 20Y AVG
+120.40%
SECTOR MEDIAN · HEALTHCARE
13.01%
median of 84 covered companies
CURRENT VS SECTOR MEDIAN
+587.42%
vs the sector median at left
NRC Health
Market Cap
$441.04M
Return on Equity (ROE)
89.43%
TTM Avg
87.53%
3Y Avg
75.48%
5Y Avg
64.30%
Market Cap
$352.34M
Return on Equity (ROE)
-28.18%
TTM Avg
-0.06%
3Y Avg
10.58%
5Y Avg
10.58%
Market Cap
$44.58M
Return on Equity (ROE)
N/A
TTM Avg
-285.38%
3Y Avg
-206.98%
5Y Avg
-151.57%
Market Cap
$1.11B
Return on Equity (ROE)
-13.54%
TTM Avg
-40.81%
3Y Avg
-170.75%
5Y Avg
-114.78%
Market Cap
$1.88B
Return on Equity (ROE)
-40.41%
TTM Avg
-45.75%
3Y Avg
-30.11%
5Y Avg
-18.95%
Market Cap
$2.95B
Return on Equity (ROE)
29.28%
TTM Avg
27.86%
3Y Avg
4.54%
5Y Avg
-12.45%
Market Cap
$4.93B
Return on Equity (ROE)
18.24%
TTM Avg
20.62%
3Y Avg
17.32%
5Y Avg
27.02%
Market Cap
$5.22B
Return on Equity (ROE)
8.67%
TTM Avg
8.42%
3Y Avg
7.80%
5Y Avg
5.80%
Market Cap
$5.83B
Return on Equity (ROE)
-161.00%
TTM Avg
-110.38%
3Y Avg
-86.51%
5Y Avg
-75.97%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| NRC Health (NRC) | $441.04M | 89.43% | 87.53% | 75.48% | 64.30% |
| Shoulder Innovations, Inc. (SI)vs › | $352.34M | -28.18% | -0.06% | 10.58% | 10.58% |
| PDS Biotechnology Corporation (PDSB)vs › | $44.58M | N/A | -285.38% | -206.98% | -151.57% |
| Teladoc Health, Inc. (TDOC)vs › | $1.11B | -13.54% | -40.81% | -170.75% | -114.78% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.88B | -40.41% | -45.75% | -30.11% | -18.95% |
| TransMedics Group, Inc. (TMDX)vs › | $2.95B | 29.28% | 27.86% | 4.54% | -12.45% |
| Doximity, Inc. (DOCS)vs › | $4.93B | 18.24% | 20.62% | 17.32% | 27.02% |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.22B | 8.67% | 8.42% | 7.80% | 5.80% |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.83B | -161.00% | -110.38% | -86.51% | -75.97% |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.56B | -43.83% | 25.09% | 5.57% | 0.40% |
ROE
89.4%
ROA
4.3%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | 89.43% |
| 2026-03-31 | 66.94% |
| 2025-12-31 | 82.91% |
| 2025-09-30 | 114.31% |
| 2025-06-30 | 84.06% |
| 2025-03-31 | 81.59% |
| 2024-12-31 | 79.22% |
| 2024-09-30 | 78.21% |
| 2024-06-30 | 72.81% |
| 2024-03-31 | 82.19% |
| 2023-12-31 | 63.26% |
| 2023-09-30 | 49.69% |
| 2023-06-30 | 37.52% |
| 2023-03-31 | 40.48% |
| 2022-12-31 | 44.14% |
| 2022-09-30 | 51.34% |
| 2022-06-30 | 52.68% |
| 2022-03-31 | 45.13% |
| 2021-12-31 | 43.90% |
| 2021-09-30 | 43.36% |
| 2021-06-30 | 47.10% |
| 2021-03-31 | 47.42% |
| 2020-12-31 | 57.93% |
| 2020-09-30 | 66.54% |
| 2020-06-30 | 79.56% |
| 2020-03-31 | 96.29% |
| 2019-12-31 | 98.28% |
| 2019-09-30 | 108.40% |
| 2019-06-30 | 116.63% |
| 2019-03-31 | 135.62% |
| 2018-12-31 | 156.94% |
| 2018-09-30 | 95.02% |
| 2018-06-30 | 96.17% |
| 2018-03-31 | 24.72% |
| 2017-12-31 | 25.29% |
| 2017-09-30 | 24.73% |
| 2017-06-30 | 25.66% |
| 2017-03-31 | 24.95% |
| 2016-12-31 | 24.57% |
| 2016-09-30 | 25.27% |
| 2016-06-30 | 25.04% |
| 2016-03-31 | 25.55% |
| 2015-12-31 | 23.52% |
| 2015-09-30 | 18.13% |
| 2015-06-30 | 18.00% |
| 2015-03-31 | 18.40% |
| 2014-12-31 | 20.69% |
| 2014-09-30 | 20.65% |
| 2014-06-30 | 20.81% |
| 2014-03-31 | 21.30% |
| 2013-12-31 | 21.58% |
| 2013-09-30 | 22.83% |
| 2013-06-30 | 24.01% |
| 2013-03-31 | 26.17% |
| 2012-12-31 | 26.56% |
| 2012-09-30 | 22.63% |
| 2012-06-30 | 22.22% |
| 2012-03-31 | 20.47% |
| 2011-12-31 | 20.82% |
| 2011-09-30 | 18.69% |
| 2011-06-30 | 18.07% |
| 2011-03-31 | 17.26% |
| 2010-12-31 | 17.49% |
| 2010-09-30 | 19.23% |
| 2010-06-30 | 19.45% |
| 2010-03-31 | 19.45% |
| 2009-12-31 | 19.22% |
| 2009-09-30 | 19.14% |
| 2009-06-30 | 19.66% |
| 2009-03-31 | 20.13% |
| 2008-12-31 | 19.29% |
| 2008-09-30 | 16.81% |
| 2008-06-30 | 18.72% |
| 2008-03-31 | 19.40% |
| 2007-12-31 | 16.17% |
| 2007-09-30 | 16.19% |
| 2007-06-30 | 16.69% |
| 2007-03-31 | 16.48% |
| 2006-12-31 | 16.01% |
| 2006-09-30 | 17.65% |
| 2006-06-30 | 17.39% |
| 2006-03-31 | 16.85% |
| 2005-12-31 | 16.06% |
| 2005-09-30 | 13.54% |
| 2005-06-30 | 13.26% |
| 2005-03-31 | 11.78% |
| 2004-12-31 | 12.99% |
| 2004-09-30 | 14.52% |
| 2004-06-30 | 13.63% |
| 2004-03-31 | 14.26% |
| 2003-12-31 | 13.52% |
| 2003-09-30 | 13.97% |
| 2003-06-30 | 15.01% |
